Colorado PROFILES, The Colorado Clinical and Translational Sciences Institute (CCTSI)
Keywords
Last Name
Institution

Connection

Emily Gorell to Male

This is a "connection" page, showing publications Emily Gorell has written about Male.

 
Connection Strength
 
 
 
0.105
 
  1. Gorell ES, Leung TH, Khuu P, Lane AT. Purified type I collagen wound matrix improves chronic wound healing in patients with recessive dystrophic epidermolysis bullosa. Pediatr Dermatol. 2015 Mar-Apr; 32(2):220-5.
    View in: PubMed
    Score: 0.016
  2. Gorell E, Lee C, Muñoz C, Chang AL. Adoption of Western culture by Californian Asian Americans: attitudes and practices promoting sun exposure. Arch Dermatol. 2009 May; 145(5):552-6.
    View in: PubMed
    Score: 0.011
  3. Shahin MM, Gorell ES, Iqneibi M, Sun Q, Brunner HI, Hellmann J, Marathe KS. Characterization of TNF-Alpha Inhibitor Induced Paradoxical Psoriasiform Dermatitis at a Single Center via Retrospective Chart Review. Pediatr Dermatol. 2026 Jan-Feb; 43(1):84-87.
    View in: PubMed
    Score: 0.008
  4. Tang JY, Marinkovich MP, Wiss K, McCarthy D, Truesdale A, Chiou AS, Eid E, McIntyre JK, Bailey I, Furukawa LK, Gorell ES, Harris N, Khosla RK, Peter Lorenz H, Lu Y, Nazaroff J, Grachev ID, Moore AJ. Prademagene zamikeracel for recessive dystrophic epidermolysis bullosa wounds (VIITAL): a two-centre, randomised, open-label, intrapatient-controlled phase 3 trial. Lancet. 2025 Jul 12; 406(10499):163-173.
    View in: PubMed
    Score: 0.008
  5. Pathmarajah P, Eid E, Nazaroff J, So J, Mittal V, Harris N, Li S, Lucky AW, Gorell ES, Peoples KG, Pope E, Lara-Corrales I, Paller AS, Wiss K, Perman MJ, Eichenfield LF, Levy ML, Morel KD, García-Romero MT, McCuaig CC, Saber M, Marinkovich MP, Oro A, Bruckner AL, Tang JY. Functional genotype classification groups distinguish disease severity in recessive dystrophic epidermolysis bullosa. Br J Dermatol. 2025 04 28; 192(5):917-925.
    View in: PubMed
    Score: 0.008
  6. Sabharwal K, Blanchard I, Gorell ES, Iqneibi M, Lucky AW, Worhunsky DJ. Junctional Epidermolysis Bullosa With Pyloric Atresia Complicated by Esophageal Atresia and Nephrotic Syndrome: A Case Report and Review of the Literature. Pediatr Dermatol. 2025 Jul-Aug; 42(4):849-854.
    View in: PubMed
    Score: 0.008
  7. So JY, Nazaroff J, Yenamandra VK, Gorell ES, Harris N, Fulchand S, Eid E, Dolorito JA, Marinkovich MP, Tang JY. Functional genotype-phenotype associations in recessive dystrophic epidermolysis bullosa. J Am Acad Dermatol. 2024 09; 91(3):448-456.
    View in: PubMed
    Score: 0.008
  8. Abreu Molnar B, Levin L, Yun D, Morel K, Wiss K, Wieser J, Ward C, Trice H, Garcia-Romero MT, Stephenson A, Provost A, Price HN, Perman MJ, Moxon M, Moeves B, McCuaig CC, McCarthy C, Lucky AW, Levy ML, Lee M, Lara-Corrales I, Henner N, Halliburton N, Griffith E, Gorell E, Glick S, Eichenfield L, Collins C, Bruckner AL, Boulrice B, Bayliss S, Badger K, Paller AS. Inpatient management of epidermolysis bullosa: Consensus-based hands-on instructions for neonates and postneonates. J Am Acad Dermatol. 2024 08; 91(2):290-299.
    View in: PubMed
    Score: 0.008
  9. Singh A, Gorell ES, Lucky AW. Topical everolimus therapy for epidermal nevi associated with woolly hair nevus in a patient with a mosaic HRAS mutation. Pediatr Dermatol. 2024 Sep-Oct; 41(5):871-873.
    View in: PubMed
    Score: 0.008
  10. Eichstadt S, Barriga M, Ponakala A, Teng C, Nguyen NT, Siprashvili Z, Nazaroff J, Gorell ES, Chiou AS, Taylor L, Khuu P, Keene DR, Rieger K, Khosla RK, Furukawa LK, Lorenz HP, Marinkovich MP, Tang JY. Phase 1/2a clinical trial of gene-corrected autologous cell therapy for recessive dystrophic epidermolysis bullosa. JCI Insight. 2019 10 03; 4(19).
    View in: PubMed
    Score: 0.006
  11. Siprashvili Z, Nguyen NT, Gorell ES, Loutit K, Khuu P, Furukawa LK, Lorenz HP, Leung TH, Keene DR, Rieger KE, Khavari P, Lane AT, Tang JY, Marinkovich MP. Safety and Wound Outcomes Following Genetically Corrected Autologous Epidermal Grafts in Patients With Recessive Dystrophic Epidermolysis Bullosa. JAMA. 2016 Nov 01; 316(17):1808-1817.
    View in: PubMed
    Score: 0.004
  12. Danial C, Adeduntan R, Gorell ES, Lucky AW, Paller AS, Bruckner AL, Pope E, Morel KD, Levy ML, Li S, Gilmore ES, Lane AT. Evaluation of Treatments for Pruritus in Epidermolysis Bullosa. Pediatr Dermatol. 2015 Sep-Oct; 32(5):628-34.
    View in: PubMed
    Score: 0.004
  13. Danial C, Adeduntan R, Gorell ES, Lucky AW, Paller AS, Bruckner A, Pope E, Morel KD, Levy ML, Li S, Gilmore ES, Lane AT. Prevalence and characterization of pruritus in epidermolysis bullosa. Pediatr Dermatol. 2015 Jan-Feb; 32(1):53-9.
    View in: PubMed
    Score: 0.004
  14. Sbicca JA, Gorell ES, Kanzler MH, Lane AT. The integrity of the dermatology National Resident Matching Program: results of a national study. J Am Acad Dermatol. 2010 Oct; 63(4):594-601.
    View in: PubMed
    Score: 0.003
  15. Barreto-Chang OL, Gorell ES, Yamaguma MA, Lane AT. Diagnosis of pilomatricoma using an otoscope. Pediatr Dermatol. 2010 Sep-Oct; 27(5):554-7.
    View in: PubMed
    Score: 0.003
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.

Copyright © 2026 The Regents of the University of Colorado, a body corporate. All rights reserved. (Harvard PROFILES RNS software version: 2.11.1)